Corcept Therapeutics
CORT
#2078
Rank
NZ$15.70 B
Marketcap
NZ$149.05
Share price
1.71%
Change (1 day)
47.55%
Change (1 year)

Corcept Therapeutics (CORT) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$1.42 Billion

According to Corcept Therapeutics 's latest financial reports the company's total assets are NZ$1.42 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Corcept Therapeutics - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$1.49 B51.65%
2023-12-31NZ$0.98 B6.95%
2022-12-31NZ$0.91 B48.12%
2021-12-31NZ$0.62 B-21.7%
2020-12-31NZ$0.79 B29.43%
2019-12-31NZ$0.61 B31.75%
2018-12-31NZ$0.46 B49.64%
2017-12-31NZ$0.31 B212.86%
2016-12-31NZ$99.25 M30.88%
2015-12-31NZ$75.83 M71.58%
2014-12-31NZ$44.19 M-42.42%
2013-12-31NZ$76.75 M-36.32%
2012-12-31NZ$0.12 B136.19%
2011-12-31NZ$51.03 M56.85%
2010-12-31NZ$32.53 M-3.58%
2009-12-31NZ$33.74 M-0.97%
2008-12-31NZ$34.07 M47.1%
2007-12-31NZ$23.16 M64.81%
2006-12-31NZ$14.05 M-68.14%
2005-12-31NZ$44.11 M-34.1%
2004-12-31NZ$66.94 M269.41%
2003-12-31NZ$18.12 M-56.48%
2002-12-31NZ$41.64 M-28.71%
2001-12-31NZ$58.42 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$333.76 B 23,311.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 11,663.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$185.71 B 12,926.72%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$198.95 B 13,855.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.31 B 25,243.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 15,629.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.63 B-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.85 B-39.94%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$13.18 B 824.58%๐Ÿ‡บ๐Ÿ‡ธ USA